跳至主要内容
临床试验/NCT04916327
NCT04916327
招募中
不适用

Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

Virginia Commonwealth University1 个研究点 分布在 1 个国家目标入组 720 人2021年8月23日

概览

阶段
不适用
干预措施
Antioxidant
疾病 / 适应症
Peripheral Vascular Diseases
发起方
Virginia Commonwealth University
入组人数
720
试验地点
1
主要终点
Arm Vascular Function at Rest (Flow Mediated Dilation Test)
状态
招募中
最后更新
上个月

概览

简要总结

The purpose of this research study is to examine the role oxidants, substances produced in the blood that can damage blood vessel function, may play in blood vessel function in healthy individuals as well as individuals with mental health disorders (posttraumatic stress disorder (PTSD) and/or generalized anxiety disorder (GAD)).

详细描述

Study #1 is made up of three sessions done on three separate days and the entire study can be completed in as little as two weeks. All testing sessions will take place at the Exercise Physiology Research Laboratory. Volunteers will be asked to participate in one initial testing session (Visit 1) lasting \< 1 hour that will help make them more familiar with the study equipment and procedures, determine body measures (height, weight, body fat), determine the maximum strength of their forearm and calf, and require one blood draw. The following two testing sessions (Visits 2 and 3) with each session lasting between 2-3 hours that will involve multiple tests designed to determine the health of their blood vessels. For Visit #2 they will be randomly given either antioxidant pills or placebo pills to determine the effect of oxidants on blood vessel health. For Visit #3, they will be given whatever set of pills (antioxidant or placebo) that they did not receive during Visit #2.

注册库
clinicaltrials.gov
开始日期
2021年8月23日
结束日期
2026年4月1日
最后更新
上个月
研究类型
Interventional
研究设计
Crossover
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
  • for PTSD group, a score of ≥ 33 on PCL-5 checklist
  • for GAD group, a score of ≥ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist
  • for Healthy Control group, a score of ≤ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist

排除标准

  • taking medications that could influence cardiovascular function
  • current smokers who have recently quit smoking
  • illicit drug use or excessive alcohol consumption
  • pregnant women
  • significant calorie restriction or vitamin/mineral deficiencies
  • limited English proficiency

研究组 & 干预措施

Antioxidant then Placebo

Subjects will ingest an antioxidant cocktail prior to their second visit and a placebo prior to third second visit

干预措施: Antioxidant

Antioxidant then Placebo

Subjects will ingest an antioxidant cocktail prior to their second visit and a placebo prior to third second visit

干预措施: Placebo

Placebo then Antioxidant

Subjects will ingest a placebo prior to their second visit and an antioxidant cocktail prior to their third visit.

干预措施: Antioxidant

Placebo then Antioxidant

Subjects will ingest a placebo prior to their second visit and an antioxidant cocktail prior to their third visit.

干预措施: Placebo

结局指标

主要结局

Arm Vascular Function at Rest (Flow Mediated Dilation Test)

时间窗: Baseline to the end of the final visit, about 2 weeks

Change in Brachial Artery Dilation from Baseline Values

Arm Vascular Function in Response to Exercise (Handgrip Exercise Test)

时间窗: Baseline to the end of the final visit, about 2 weeks

Change in Brachial Artery Dilation from Baseline Values

Leg Vascular Function (Passive Leg Movement Test)

时间窗: Baseline to the end of the final visit, about 2 weeks

Change in Leg Blood Flow Values from Baseline

研究点 (1)

Loading locations...

相似试验